Země: Izrael
Jazyk: hebrejština
Zdroj: Ministry of Health
CABAZITAXEL 60 MG / 1.5 ML
SANOFI - AVENTIS ISRAEL LTD
L01CD04
CONCENTRATE FOR SOLUTION FOR INFUSION
I.V
SANOFI - AVENTIS DEUTSCHLAND GMBH, GERMANY
CABAZITAXEL
In combination with prednisone for the treatment of patients with metastatic hormone refractory prostate cancer (mHRPC) previously treated with a docetaxel-based treatment regimen
2012-11-01